Financial Ratios

ARVIND REMEDIES LTD.

NSE : NABSE : 531823ISIN CODE : INE211C01037Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.700 (0 %)
PREV CLOSE ( ) 4.70
OPEN PRICE ( ) 4.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2850
TODAY'S LOW / HIGH ( )4.70 4.70
52 WK LOW / HIGH ( ) 4.74.7
NSE
This Company is not listed in NSE
Select year
ParticularsJun2015Mar2014Mar2013Mar2012Mar2011
Operational & Financial Ratios
   Earnings Per Share (Rs)-46.988.658.420.400.35
   CEPS(Rs)-42.6510.6911.034.704.01
   DPS(Rs)0.000.801.000.070.07
   Book NAV/Share(Rs)-7.2939.9435.402.812.52
   Tax Rate(%)1.6131.8335.0747.8425.77
Margin Ratios
   Core EBITDA Margin(%)-5.4818.3018.9814.8610.94
   EBIT Margin(%)-32.3016.9117.2814.2410.39
   Pre Tax Margin(%)-41.338.938.888.166.04
   PAT Margin (%)-40.666.095.774.264.48
   Cash Profit Margin (%)-36.927.537.554.975.13
Performance Ratios
   ROA(%)-34.136.095.623.995.30
   ROE(%)-287.7626.6026.5115.0918.90
   ROCE(%)-31.8820.4220.2216.1814.98
   Asset Turnover(x)0.841.000.980.941.18
   Sales/Fixed Asset(x)2.132.902.632.897.11
   Working Capital/Sales(x)-8.586.876.768.134.84
Efficiency Ratios
   Fixed Capital/Sales(x)0.470.350.380.350.14
   Receivable days187.91108.41106.58121.83116.70
   Inventory Days46.7959.5654.1057.9649.77
   Payable days23.7643.9834.3838.7346.95
Valuation Parameters
   PER(x)0.004.993.6656.6666.20
   PCE(x)-0.294.042.794.865.79
   Price/Book(x)-1.701.080.870.810.92
   Yield(%)0.001.853.253.073.02
   EV/Net Sales(x)1.061.000.971.030.76
   EV/Core EBITDA(x)-22.285.144.806.606.61
   EV/EBIT(x)-3.275.575.306.937.01
   EV/CE(x)1.060.830.770.750.74
   M Cap / Sales0.110.320.220.250.31
Growth Ratio
   Net Sales Growth(%)-13.6137.1652.1320.4321.76
   Core EBITDA Growth(%)-121.0232.0797.0463.9231.78
   EBIT Growth(%)-255.4834.3087.4765.8232.64
   PAT Growth(%)-643.3745.01109.2614.8358.90
   EPS Growth(%)-643.372.661992.8214.82-14.33
Financial Stability Ratios
   Total Debt/Equity(x)-15.102.293.052.671.51
   Current Ratio(x)0.841.271.321.231.50
   Quick Ratio(x)0.830.900.950.871.13
   Interest Cover(x)-3.582.122.062.342.39
   Total Debt/Mcap(x)8.862.123.503.291.64

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.